Related Experiment Video
Updated: Jun 17, 2026
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Hb H disease: clinical course and disease modifiers
Suthat Fucharoen1, Vip Viprakasit
1Thalassemia Research Center, Institute of Molecular Biosciences, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand. grsfc@mahidol.ac.th
Hematology. American Society of Hematology. Education Program
|December 17, 2009
Summary
Hemoglobin H (Hb H) disease, a common thalassemia intermedia, presents varied management needs. Non-deletional forms can cause severe anemia, highlighting the role of genetic and environmental factors in disease severity.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Hemoglobin H (Hb H) disease is a prevalent form of thalassemia intermedia.
- It requires careful management due to its diverse clinical manifestations.
Purpose of the Study:
- To review the clinical features and management considerations for Hemoglobin H disease.
- To discuss the genetic basis and variability in clinical severity, particularly for non-deletional Hb H disease.
Main Methods:
- Review of existing literature on Hemoglobin H disease.
- Analysis of genotype-phenotype correlations in patients with Hb H disease.
Main Results:
- Hb H disease typically results from alpha(0)-thalassemia interacting with deletional alpha(+)-thalassemia.
- Non-deletional mutations or interactions with abnormal hemoglobins can lead to more severe anemia and splenomegaly.
- Patients with identical genotypes can exhibit different clinical severities, suggesting modifying factors.
Conclusions:
- Management of Hb H disease requires consideration of its genetic heterogeneity.
- Non-deletional Hb H disease may necessitate transfusions, and its severity is influenced by factors beyond genotype.
- Further research into genetic and environmental modifiers is needed for personalized treatment strategies.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...